GENinCode (LSE:GENI) FCF Margin % : -250.91% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is GENinCode FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. GENinCode's Free Cash Flow for the six months ended in Dec. 2023 was £-3.04 Mil. GENinCode's Revenue for the six months ended in Dec. 2023 was £1.21 Mil. Therefore, GENinCode's FCF Margin % for the quarter that ended in Dec. 2023 was -250.91%.

As of today, GENinCode's current FCF Yield % is -62.01%.

The historical rank and industry rank for GENinCode's FCF Margin % or its related term are showing as below:

LSE:GENI' s FCF Margin % Range Over the Past 10 Years
Min: -349.26 Med: -300.27 Max: -115.09
Current: -349.26

During the past 5 years, the highest FCF Margin % of GENinCode was -115.09%. The lowest was -349.26%. And the median was -300.27%.

LSE:GENI's FCF Margin % is ranked worse than
86.43% of 221 companies
in the Medical Diagnostics & Research industry
Industry Median: -11.47 vs LSE:GENI: -349.26

GENinCode FCF Margin % Historical Data

The historical data trend for GENinCode's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GENinCode FCF Margin % Chart

GENinCode Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

-115.09

-280.68

-319.86

-349.26

GENinCode Semi-Annual Data
	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial			-398.19	-309.64	-328.72	-474.53	-250.91

Competitive Comparison of GENinCode's FCF Margin %

For the Diagnostics & Research subindustry, GENinCode's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GENinCode's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, GENinCode's FCF Margin % distribution charts can be found below:

* The bar in red indicates where GENinCode's FCF Margin % falls into.

GENinCode FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

GENinCode's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-7.544	/	2.16
	=	-349.26 %

GENinCode's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-3.036	/	1.21
	=	-250.91 %

GENinCode FCF Margin % Related Terms

Thank you for viewing the detailed overview of GENinCode's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

GENinCode (LSE:GENI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » GENinCode PLC (LSE:GENI) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Oxford Science Park, John Eccles House, Robert Robertson Avenue, Oxford, GBR, OX4 4GP

Website

https://www.genincode.com

GENinCode PLC is engaged in the genetic risk assessment, prediction, and prevention of cardiovascular diseases including coronary artery diseases such as angina and myocardial infarction (heart attack), stroke, heart failure, hypertension, and other vascular heart diseases. The company's current product portfolio comprises Cardio inCode, LiPID inCode, SuDD inCode, and Thrombo inCode. The company has only one reportable segment being sale of kits and provision of support services. The Geographic Markets of the group are Chile, France, Italy, Sweden, Mexico, Spain and United Kingdom.